Results 11 to 20 of about 478,988 (359)
Hepatoid Adenocarcinoma of the Lung [PDF]
Hepatoid adenocarcinoma of the lung (HAL) is an comparatively rare malignant tumor originating from the lung with shorter survival. HAL morphologically and pathologically exhibits hepatocellular carcinoma (HCC)-like characteristics, while its clinical features resemble pulmonary adenocarcinoma.
Meihui Li, Ying Fan, Hongyang Lu
openaire +3 more sources
Adenocarcinoma of the lung [PDF]
The clinical and histological features of 53 cases of adenocarcinoma of the lung are presented. In more than one-third of the patients the tumour was a solitary nodule, raising the possibility that it might be a metastatic focus. Although histological features may suggest an origin from such sources as the kidney, uterus, ovary or bowel, nearly all ...
J R, Hinds, G C, Hitchcock
openaire +2 more sources
Hepatoid adenocarcinoma of the lung [PDF]
Learning Point for Clinicians Hepatoid adenocarcinoma of lung is a rare type of lung cancer which is defined as an α-fetoprotein—producing primary carcinoma with morphological features similar to hepatocellular carcinoma. Establishing the diagnosis of HAL is worthwhile because of the potential for altered management. A 79-year-old Chinese male smoker
G-Q, Qian, F-Y, Yin, G-X, Li, J-G, Chu
openaire +2 more sources
Transcriptomic Microenvironment of Lung Adenocarcinoma [PDF]
Abstract Background: Tissues surrounding tumors are increasingly studied to understand the biology of cancer development and identify biomarkers. Methods: A unique geographic tissue sampling collection was obtained from patients that underwent curative lobectomy for stage I pulmonary adenocarcinoma.
Yohan, Bossé +8 more
openaire +2 more sources
miR-625-5p promotes proliferation and invasion of lung adenocarcinoma by targeting PRKACA [PDF]
Background and purpose: Lung adenocarcinoma is a subtype of non-small cell lung cancer. Although much progress has been made in the diagnosis and treatment of lung adenocarcinoma, the clinical prognosis and overall survival of advanced lung  ...
HU Yaqiong , BAI Jun , CHEN Lin , CHEN Xinlu , ZHANG Liping , ZHOU Dandan , WANG Yu , YIN Chonggao , LI Hongli , LIU Yuqing
doaj +1 more source
Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival [PDF]
LDL receptor-related proteins (LRPs) are transmembrane receptors involved in endocytosis, cell-signaling, and trafficking of other cellular proteins. Considerable work has focused on LRPs in the fields of vascular biology and neurobiology.
Gilder, Andrew S. +4 more
core +10 more sources
Papillary Adenocarcinoma: A Rare Subtype of Lung Adenocarcinoma
Papillary adenocarcinoma (PA) of the lung is a specific form of lung cancer characterized by papillary structures in tumor cells. This type of cancer is relatively rare and has distinct pathological and radiological features that differentiate it from other types of lung adenocarcinomas.
Thouil, Afaf +4 more
openaire +2 more sources
Follistatin is a novel biomarker for lung adenocarcinoma in humans. [PDF]
Follistatin (FST), a single chain glycoprotein, is originally isolated from follicular fluid of ovary. Previous studies have revealed that serum FST served as a biomarker for pregnancy and ovarian mucinous tumor.
Fangfang Chen +7 more
doaj +1 more source
Massive malignant pleural effusion due to lung adenocarcinoma in 13-year-old boy [PDF]
A 13-year-old boy with no risk factors for lung cancer presented with a massive left-sided pleural effusion and a mediastinal shift on chest radiography and computed tomography. A chest tube drained bloody pleural fluid with an exudative pattern.
Afghani, R. +5 more
core +1 more source
BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma. [PDF]
Lung cancer is one of the most malignant tumors and the leading cause of cancer-related deaths worldwide. Among lung cancers, 40% are diagnosed as adenocarcinoma. Bromodomain containing 7 (BRD7) is a member of bromodomain-containing protein family.
Yushun Gao, Bing Wang, Shugeng Gao
doaj +1 more source

